Delirium treatment at the surgical ward (DELTa S)Treatment of delirium: rivastigmine or haloperidol as primary treatment for delirium in elderly patients with a fractured hip. A randomized placebo-controlled study.
Suspended
- Conditions
- Delirium treatment on a surgical ward.
- Registration Number
- NL-OMON29441
- Lead Sponsor
- trial medication sponsored by Novartis
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Suspended
- Sex
- Not specified
- Target Recruitment
- 100
Inclusion Criteria
Patients with a fractured hip, admitted on a surgical ward.
Exclusion Criteria
Already use of Haloperidol/Rivastigmine/Donepezil/Galantamine.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ength of delirium.
- Secondary Outcome Measures
Name Time Method 1. Length of stay hospital;<br /><br>2. Severity of delirium;<br /><br>3. Functional outcome 3,6,13 weeks after delirium;<br /><br>4. Need of escape medication;<br /><br>5. Cognition;<br /><br>6. Adverse events.